every day I meet all sorts of people-- small business owners, working moms, students, seniors, and servicemembers--and they are concerned about all sorts of things: the growing cost of healthcare, the cost of child care, the cost of college, the cost of student loan debt, stagnant wages, fixing our broken criminal justice system, gun violence in schools--you name it. But in the thousands of conversations I have had, I haven't met a single person who has said they are concerned that Washington doesn't work well enough for big businesses. If you ask any of them, they will tell you that, when it comes to the wealthy and the powerful, Washington works just like a dream, but for everyone else, Washington just isn't working. That is not a coincidence. Powerful interests have been working for years to capture every single branch of government to tilt the scales in their favor and against everyone else. Our courts are no exception in this. Powerful interests have worked for years, pouring incredible amounts of money into capturing our courts. It has been a real one-two punch. The first punch has been working with Republicans to stop fair- minded, impartial judges from sitting on the Federal bench, slowing down or stopping those nominations, holding open a Supreme Court seat, and keeping fair people off the bench whenever possible. Then came the second punch.…
On the recordAugust 1, 2018
Source
govinfo.govShare
More from Elizabeth Warren
Jul 17, 2026
We’re in an emergency situation, and we need to be using all the tools we have to make more medicines here at home, and that should include federal contracting and procurement policy.
Jul 22, 2026
When giant corporations and Wall Street investors buy up all the fire truck manufacturers, it’s a threat to public safety.
Jul 21, 2026
Abdul is the only candidate in this race not taking corporate money, and he's fighting to get money out of politics altogether. Abdul's studied to be a doctor, and he is fighting for every single American to have affordable, high-quality…
Jul 17, 2026
We need more visibility into what’s happening in these transactions when it has the potential to influence such an important part of our pharmaceutical chain.





